<DOC>
	<DOCNO>NCT01991431</DOCNO>
	<brief_summary>This international multi-center , prospective , observational registry consecutive patient enrollment intend determine outcome Parameters within 30 day transaortic transcatheter aortic valve replacement .</brief_summary>
	<brief_title>ROUTE Registry Of Utilisation Transaortic ( Tao ) TAVI Approach Using Edwards Sapien XT Valve</brief_title>
	<detailed_description>The purpose registry expand upon exist data set , identify patient characteristic indicator related complication clinical benefit patient symptomatic severe calcific degenerative aortic stenosis undergo transaortic transcatheter procedure commercially available Edwards SAPIEN XT Transcatheter Heart Valve Ascendra+ System .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Intended transaortic ( Tao ) TAVI use Edwards SAPIEN XT Transcatheter Heart Valve Ascendra+ DeliverySystem Compliance indication accord Instructions Use Written inform consent Presence contraindication Instructions Use TAo concomitant procedure ( e.g . Tao + CABG ) Participation SOURCE XT registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>